AI-generated summary
The authors conducted a scoping review of 19 studies on low-level laser therapy for osteoradionecrosis, mapping how it has been used for treatment and prevention. They report that the studies suggested LLLT can be used for therapeutic and preventive purposes. The clinical evidence consists mainly of case reports, and laser parameters varied and were often incompletely reported, which the authors say makes standardized protocols and effectiveness hard to establish.
- Studies included
- 19
- Who or what was studied
- unclear
- Wavelengths
- 660, 780, 904 nm
- Limits stated in the abstract
- Clinical evidence is mainly case reports, laser parameters varied and were incompletely reported, and the authors call for well-designed, large-scale clinical trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 to 904 nm, 660 to 904 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Near-infrared, Wavelength, Photodynamic therapy, Photobiomodulation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.